Dr Joshua Hare Discusses Stem Cell Clinical Trials and What Doctors Should Know

Today on the DocPreneur Leadership Podcast at Concierge Medicine Today we sit down with Dr. Joshua Hare Chief Science Officer at Longeveron, a life sciences company developing biological solutions for aging and aging-associated diseases through the testing of allogeneic human Mesenchymal Stem Cells (MSCs) that are derived from the bone marrow of young, healthy donors.

 

Dr. Hare is also the Founding Director of the University of Miami Interdisciplinary Stem Cell Institute (ISCI). Through his work with ISCI, Hare has made significant advances in the field of stem cell regenerative medicine, including the creation of relevant intellectual property.

 

Dr. Joshua Hare co-founded Longeveron in 2014 utilizing intellectual property and technology exclusively licensed from the University of Miami, where he is also the Founding Director of the university’s Interdisciplinary Stem Cell Institute (ISCI). Through his work with ISCI, Hare has made significant advances in the field of stem cell regenerative medicine, including the creation of relevant intellectual property.

 

A graduate of the University of Pennsylvania (1984) and the Johns Hopkins University School of Medicine (1988), Hare completed fellowships at Johns Hopkins and Brigham and Women’s Hospital in Boston, Ma. He served as a research fellow at Harvard University and is Board Certified in cardiovascular medicine. During his career, Hare has championed the field of allogeneic cell therapy, and he has conducted five clinical trials using allogenic cell therapy. Hare’s publications in the area of cell-based therapy are widely cited, and he holds six Investigational New Drug (IND) authorizations from the FDA for cell therapy drugs and treatments in patients with heart disease. Hare co-founded Longeveron as a means to bring his academic findings to patients with unmet medical needs.

 

Hare’s extensive list of accolades and professional experience includes: Director, Interdisciplinary Stem Cell Institute (ISCI) Louis Lemberg Professor of Medicine (cardiology), Leonard M. Miller School of Medicine, University of Miami Professor of Biomedical Engineering Professor of Molecular and Cellular Pharmacology Professor of Cell Biology and Anatomy Nominated in 2011 to the Association of American Physicians Stem cell therapy is emerging as a promising new treatment option for chronic diseases and injuries affecting various organ systems.

 

One of the most exciting ideas emerging from the field of regenerative medicine is the theory that stem cells can treat aging-related disability and frailty, reducing inflammation and improving functional capacity and quality of life for human beings. Stem cells have the potential to increase longevity and could ameliorate diseases and disorders associated with aging. Currently there are no FDA-approved allogeneic mesenchymal stem cell treatments in the United States. Longeveron's LMSCs are currently undergoing rigorous testing for safety and efficacy in Phase I and II clinical trials. They hope to be the first to offer stem cells as a safe, effective, FDA-approved treatment for some of the world’s most difficult chronic and life-threatening conditions such as Aging Frailty, Alzheimer’s disease and the Metabolic Syndrome.

 

© Concierge Medicine Today, LLC. ("CMT") All rights reserved.

 

Disclaimers: All content presented here is for general information purposes only. It is NOT intended to provide medical, legal, professional, accounting or financial advice. No warranties or guarantees are assumed or implied and user(s) releases Concierge Medicine Today, LLC, its agents, representatives, affiliated brands/companies and/or guests from all damages, liability and/or claims. Be advised, some references, companies, individuals, products, services, resources and/or links may be out-of-date. Concierge Medicine Today, LLC does not update content past its release date. User(s) assume all risk and liability with any use of the content as well as third party links. Concierge Medicine Today, LLC., has no formal peer review and, therefore, cannot guarantee the validity of information and/or content contained on its web sites, podcasts, and/or all content it produces or releases. While some of our speakers may be licensed Physicians, they are not your Physician. Please consult your Physician related to anything you may have read or heard or have questions about or call 911. The views, thoughts, and opinions expressed are the speaker’s own and do not necessarily represent the views, thoughts, and/or opinions of Concierge Medicine Today, LLC. The "Concierge Medicine Today, LLC" ("CMT") name and all forms and abbreviations are the property of its owner and its use does not imply endorsement of or opposition to any specific organization, product, or service. Additional disclaimers, releases, terms of use and conditions apply also to the production and/or use of this content, https://conciergemedicinetoday.org/tcpp/.